Procter & Gamble (NYSE:PG) Price Target Raised to $166.00

Procter & Gamble (NYSE:PG) had its target price lifted by TD Cowen from $150.00 to $166.00 in a research note published on Friday morning, Marketbeat reports. TD Cowen currently has a hold rating on the stock.

PG has been the subject of a number of other research reports. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $166.00 target price on shares of Procter & Gamble in a report on Tuesday, October 20th. Barclays upped their target price on shares of Procter & Gamble from $146.00 to $152.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 21st. Sanford C. Bernstein reissued a “market perform” rating and issued a $149.00 price target on shares of Procter & Gamble in a research note on Monday, August 24th. Jefferies Financial Group raised their price target on Procter & Gamble from $177.00 to $179.00 and gave the stock a “buy” rating in a research report on Friday, June 26th. Finally, Bank of America dropped their price objective on Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a report on Friday, July 10th. Fifteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $168.90.

Procter & Gamble Stock Up 0.1%

Shares of NYSE PG opened at $161.21 on Friday. The firm has a market capitalization of $373.64 billion, a PE ratio of 24.28, a price-to-earnings-growth ratio of 4.00 and a beta of 0.39. The company has a current ratio of 0.72, a quick ratio of 0.53 and a debt-to-equity ratio of 0.40. Procter & Gamble has a 1 year low of $137.62 and a 1 year high of $167.25. The firm’s 50-day moving average is $148.41 and its 200-day moving average is $147.12.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, topping the consensus estimate of $1.89 by $0.11. The company had revenue of $23.28 billion during the quarter, compared to analysts’ expectations of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. Procter & Gamble’s revenue was up 4.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.99 EPS. Equities analysts expect that Procter & Gamble will post 6.98 EPS for the current year.

Procter & Gamble Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be paid a dividend of $1.0885 per share. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $4.35 annualized dividend and a yield of 2.7%. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.51%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO Paul Gama sold 2,225 shares of the stock in a transaction on Monday, October 5th. The shares were sold at an average price of $145.34, for a total value of $323,381.50. Following the sale, the chief executive officer directly owned 51,124 shares in the company, valued at approximately $7,430,362.16. This trade represents a 4.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Susan Whaley sold 2,369 shares of the stock in a transaction on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $344,310.46. Following the completion of the sale, the insider owned 30,730 shares in the company, valued at approximately $4,466,298.20. This trade represents a 7.16% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 15,135 shares of company stock worth $2,189,970 over the last ninety days. 0.23% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Procter & Gamble

Several institutional investors and hedge funds have recently made changes to their positions in PG. Apollon Wealth Management LLC increased its position in shares of Procter & Gamble by 0.5% in the 3rd quarter. Apollon Wealth Management LLC now owns 100,929 shares of the company’s stock valued at $14,663,000 after buying an additional 474 shares in the last quarter. Holos Integrated Wealth LLC lifted its holdings in Procter & Gamble by 8.7% during the third quarter. Holos Integrated Wealth LLC now owns 1,607 shares of the company’s stock worth $253,000 after acquiring an additional 129 shares in the last quarter. Kingswood Wealth Advisors LLC lifted its holdings in Procter & Gamble by 1.2% during the third quarter. Kingswood Wealth Advisors LLC now owns 30,909 shares of the company’s stock worth $4,491,000 after acquiring an additional 377 shares in the last quarter. IRON Financial LLC lifted its holdings in Procter & Gamble by 105.7% during the third quarter. IRON Financial LLC now owns 12,686 shares of the company’s stock worth $1,843,000 after acquiring an additional 6,519 shares in the last quarter. Finally, Paladin Wealth LLC grew its stake in Procter & Gamble by 24.0% in the third quarter. Paladin Wealth LLC now owns 6,094 shares of the company’s stock valued at $885,000 after acquiring an additional 1,180 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Multiple analysts raised targets and maintained bullish ratings. UBS lifted its target to $190 and retained a Buy rating, while Citigroup raised its target to $187, BNP Paribas Exane to $189, and JPMorgan to $180. Freedom Broker also upgraded PG from Hold to Buy with a $176 target. These revisions suggest analysts believe the earnings improvement and resilient demand can support further gains.
• Positive Sentiment: Fiscal Q1 results exceeded expectations. Adjusted EPS was $2.00 versus the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, topping estimates of approximately $22.80 billion. Organic sales also grew 4%, with volume contributing 2.4 percentage points. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Demand and operating trends remain encouraging. Stronger volumes, favorable product mix, productivity savings, and resilient laundry and home-product sales supported the quarter. Investors also continue to value PG’s defensive business mix and 70-year record of dividend increases. P&G dividend history
• Neutral Sentiment: Fiscal 2027 guidance was mixed. The company raised its all-in sales-growth outlook, partly reflecting the Thorne acquisition, but projected revenue of $86.0 billion to $87.7 billion remains below the roughly $88.8 billion consensus. EPS guidance of $6.89 to $7.11 brackets expectations of $6.98.
• Negative Sentiment: Commodity and energy inflation remain the main risks. Higher oil, raw-material, transportation, and energy costs are expected to create an estimated $1.4 billion headwind and pressure margins. TD Cowen raised its target to $166 but kept a Hold rating, warning that cost inflation could limit the recovery. P&G commodity cost outlook

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.